REFERENCES
1. Sebastiani P, Perls TT. The genetics of extreme longevity: lessons from the new England centenarian study. Front Genet. 2012;3:277.
3. Lakatta EG. Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev. 2002;7:29-49.
4. Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin. 2012;8:143-64.
5. Belsky DW, Caspi A, Houts R, et al. Quantification of biological aging in young adults. Proc Natl Acad Sci USA. 2015;112:E4104-10.
6. Maximov VN, Malyutina SK, Orlov PS, et al. Mitochondrial DNA copy number of leucocytes as ageing marker and risk factors for age-related diseases in human. Adv Gerontol. 2019;32:422-30.
7. Willeit P, Willeit J, Brandstätter A, et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol. 2010;30:1649-56.
8. Akasheva DU, Plokhova EV, Tkacheva ON, et al. Age-related left ventricular changes and their association with leukocyte telomere length in healthy people. PLoS One. 2015;10:e0135883.
9. Sanders JL, Fitzpatrick AL, Boudreau RM, et al. Leukocyte telomere length is associated with noninvasively measured age-related disease: the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 2012;67:409-16.
10. Fitzpatrick AL, Kronmal RA, Gardner JP, et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol. 2007;165:14-21.
11. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2014;349:g4227.
12. Li K, Dai M, Sacirovic M, et al. Leukocyte telomere length and mitochondrial DNA copy number associate with endothelial function in aging-related cardiovascular disease. Front Cardiovasc Med. 2023;10:1157571.
13. van der Harst P, van der Steege G, de Boer RA, et al. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol. 2007;49:1459-64.
14. Teschendorff AE, Horvath S. Epigenetic ageing clocks: statistical methods and emerging computational challenges. Nat Rev Genet. 2025;26:350-68.
15. Fransquet PD, Wrigglesworth J, Woods RL, Ernst ME, Ryan J. The epigenetic clock as a predictor of disease and mortality risk: a systematic review and meta-analysis. Clin Epigenetics. 2019;11:62.
16. Carbonneau M, Li Y, Prescott B, et al. Epigenetic age mediates the association of life's essential 8 with cardiovascular disease and mortality. J Am Heart Assoc. 2024;13:e032743.
18. Mongelli A, Panunzi S, Nesta M, et al. Distinguishable DNA methylation defines a cardiac-specific epigenetic clock. Clin Epigenetics. 2023;15:53.
19. Pang WW, Price EA, Sahoo D, et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci USA. 2011;108:20012-7.
20. Welsh C, Welsh P, Mark PB, et al. Association of total and differential leukocyte counts with cardiovascular disease and mortality in the UK biobank. Arterioscler Thromb Vasc Biol. 2018;38:1415-23.
21. Simpson AJG. The natural somatic mutation frequency and human carcinogenesis. Adv Cancer Res. 1997;71:209-40.
22. Passegué E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med. 2005;202:1599-611.
23. Evans MA, Sano S, Walsh K. Cardiovascular disease, aging, and clonal hematopoiesis. Annu Rev Pathol. 2020;15:419-38.
24. Marnell CS, Bick A, Natarajan P. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease. J Mol Cell Cardiol. 2021;161:98-105.
25. Walsh K. The emergence of clonal hematopoiesis as a disease determinant. J Clin Invest. 2024;134:e180063.
26. Abplanalp WT, Schuhmacher B, Cremer S, et al. Cell-intrinsic effects of clonal hematopoiesis in heart failure. Nat Cardiovasc Res. 2023;2:819-34.
27. Chavkin NW, Min KD, Walsh K. Importance of clonal hematopoiesis in heart failure. Trends Cardiovasc Med. 2022;32:198-203.
29. Tall AR, Fuster JJ. Clonal hematopoiesis in cardiovascular disease and therapeutic implications. Nat Cardiovasc Res. 2022;1:116-24.
30. Jakubek YA, Reiner AP, Honigberg MC. Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations. Transl Res. 2023;255:171-80.
31. Zink F, Stacey SN, Norddahl GL, et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood. 2017;130:742-52.
32. Mitchell E, Spencer Chapman M, Williams N, et al. Clonal dynamics of haematopoiesis across the human lifespan. Nature. 2022;606:343-50.
33. Poon GYP, Watson CJ, Fisher DS, Blundell JR. Synonymous mutations reveal genome-wide levels of positive selection in healthy tissues. Nat Genet. 2021;53:1597-605.
34. Genovese G, Kähler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371:2477-87.
35. Loh PR, Genovese G, Handsaker RE, et al. Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations. Nature. 2018;559:350-5.
36. Jakubek YA, Zhou Y, Stilp A, et al. Mosaic chromosomal alterations in blood across ancestries using whole-genome sequencing. Nat Genet. 2023;55:1912-9.
37. Liu X, Kamatani Y, Terao C. Genetics of autosomal mosaic chromosomal alteration (mCA). J Hum Genet. 2021;66:879-85.
38. Lin SH, Brown DW, Rose B, et al. Incident disease associations with mosaic chromosomal alterations on autosomes, X and Y chromosomes: insights from a phenome-wide association study in the UK Biobank. Cell Biosci. 2021;11:143.
39. Leshchyk A, Xiang Q, Andersen SL, et al. Mosaic Chromosomal Alterations and Human Longevity. J Gerontol A Biol Sci Med Sci. 2023;78:1561-8.
40. Sun M, Cyr MC, Sandoval J, et al. Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors. Cancer Epidemiol Biomarkers Prev. 2023;32:776-83.
41. Forsberg LA, Gisselsson D, Dumanski JP. Mosaicism in health and disease - clones picking up speed. Nat Rev Genet. 2017;18:128-42.
42. Pierre RV, Hoagland HC. Age-associated aneuploidy: Loss of Y chromosome from human bone marrow cells with aging. Cancer. 1972;30:889-94.
43. Pierre RV, Hoagland HC. 45,X cell lines in adult men: loss of Y chromosome, a normal aging phenomenon? Mayo Clin Proc. 1971;46:52-5.
44. Jacobs PA, Brunton M, Court Brown WM, Doll R, Goldstein H. Change of human chromosome count distribution with age: evidence for a sex differences. Nature. 1963;197:1080-1.
45. Godfrey AK, Naqvi S, Chmátal L, et al. Quantitative analysis of Y-Chromosome gene expression across 36 human tissues. Genome Res. 2020;30:860-73.
46. Bellott DW, Hughes JF, Skaletsky H, et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature. 2014;508:494-9.
47. Tang D, Han Y, Lun Y, et al. Y chromosome loss is associated with age-related male patients with abdominal aortic aneurysms. Clin Interv Aging. 2019;14:1227-41.
48. Thompson DJ, Genovese G, Halvardson J, et al. Genetic predisposition to mosaic Y chromosome loss in blood. Nature. 2019;575:652-7.
49. Dumanski JP, Rasi C, Lönn M, et al. Mutagenesis. Smoking is associated with mosaic loss of chromosome Y. Science. 2015;347:81-3.
50. Forsberg LA, Rasi C, Malmqvist N, et al. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat Genet. 2014;46:624-8.
51. Liu A, Genovese G, Zhao Y, et al. Genetic drivers and cellular selection of female mosaic X chromosome loss. Nature. 2024;631:134-41.
52. Dumanski JP, Lambert JC, Rasi C, et al. Mosaic loss of chromosome Y in blood is associated with Alzheimer disease. Am J Hum Genet. 2016;98:1208-19.
53. Loftfield E, Zhou W, Graubard BI, et al. Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank. Sci Rep. 2018;8:12316.
54. Zhou W, Machiela MJ, Freedman ND, et al. Mosaic loss of chromosome Y is associated with common variation near TCL1A. Nat Genet. 2016;48:563-8.
55. Lim J, Hubbard AK, Blechter B, et al. Associations between mosaic loss of sex chromosomes and incident hospitalization for atrial fibrillation in the United Kingdom. J Am Heart Assoc. 2024;13:e036984.
56. Fan HC, Blumenfeld YJ, El-Sayed YY, Chueh J, Quake SR. Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy. Am J Obstet Gynecol. 2009;200:543.e1-7.
57. Danielsson M, Halvardson J, Davies H, et al. Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals. Eur J Hum Genet. 2020;28:349-57.
58. Tsuchiya J, Maki Y, Ayano M, et al. A novel method for acquired sex chromosome mosaicism. Adv Biol. 2024;8:e2300512.
59. Dumanski JP, Halvardson J, Davies H, et al. Immune cells lacking Y chromosome show dysregulation of autosomal gene expression. Cell Mol Life Sci. 2021;78:4019-33.
60. Mattisson J, Danielsson M, Hammond M, et al. Leukocytes with chromosome Y loss have reduced abundance of the cell surface immunoprotein CD99. Sci Rep. 2021;11:15160.
61. Horitani K, Chavkin NW, Arai Y, et al. Disruption of the Uty epigenetic regulator locus in hematopoietic cells phenocopies the profibrotic attributes of Y chromosome loss in heart failure. Nat Cardiovasc Res. 2024;3:343-55.
62. Gutiérrez-Hurtado IA, Sánchez-Méndez AD, Becerra-Loaiza DS, et al. Loss of the Y chromosome: a review of molecular mechanisms, age inference, and implications for men’s health. Int J Mol Sci. 2024;25:4230.
63. Ly P, Teitz LS, Kim DH, et al. Selective Y centromere inactivation triggers chromosome shattering in micronuclei and repair by non-homologous end joining. Nat Cell Biol. 2017;19:68-75.
64. Fukami M, Miyado M. Mosaic loss of the Y chromosome and men's health. Reprod Med Biol. 2022;21:e12445.
65. Herr LM, Schaffer ED, Fuchs KF, Datta A, Brosh RM Jr. Replication stress as a driver of cellular senescence and aging. Commun Biol. 2024;7:616.
66. Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science. 2019;366:eaan4673.
67. Wright DJ, Day FR, Kerrison ND, et al. Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility. Nat Genet. 2017;49:674-9.
68. Riaz M, Mattisson J, Polekhina G, et al. A polygenic risk score predicts mosaic loss of chromosome Y in circulating blood cells. Cell Biosci. 2021;11:205.
69. Terao C, Momozawa Y, Ishigaki K, et al. GWAS of mosaic loss of chromosome Y highlights genetic effects on blood cell differentiation. Nat Commun. 2019;10:4719.
70. Weng C, Zhao Y, Song M, et al. Mosaic loss of chromosome Y, tobacco smoking and risk of age-related lung diseases: insights from two prospective cohorts. Eur Respir J. 2024;64:2400968.
72. Siggins RW, Hossain F, Rehman T, Melvan JN, Zhang P, Welsh DA. Cigarette smoke alters the hematopoietic stem cell niche. Med Sci. 2014;2:37-50.
73. Heddle JA. The role of proliferation in the origin of mutations in mammalian cells. Drug Metab Rev. 1998;30:327-38.
74. Beckman RA, Loeb LA. Evolutionary dynamics and significance of multiple subclonal mutations in cancer. DNA Repair. 2017;56:7-15.
76. Wong JYY, Margolis HG, Machiela M, et al. Outdoor air pollution and mosaic loss of chromosome Y in older men from the Cardiovascular Health Study. Environ Int. 2018;116:239-47.
77. Schumacher B, Pothof J, Vijg J, Hoeijmakers JHJ. The central role of DNA damage in the ageing process. Nature. 2021;592:695-703.
78. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer. 2008;8:512-22.
79. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186:243-78.
80. Hozakowska-Roszkowska DM, Mengel-From J, Hristozova TK, et al. Mosaic loss of Y chromosome and the association to mortality in Danish men aged 56-100 years. Mech Ageing Dev. 2024;222:111979.
81. Sano S, Horitani K, Ogawa H, et al. Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality. Science. 2022;377:292-7.
82. Forsberg LA. Loss of chromosome Y (LOY) in blood cells is associated with increased risk for disease and mortality in aging men. Hum Genet. 2017;136:657-63.
83. Noveski P, Madjunkova S, Sukarova Stefanovska E, et al. Loss of Y chromosome in peripheral blood of colorectal and prostate cancer patients. PLoS One. 2016;11:e0146264.
84. Qin N, Li N, Wang C, et al. Association of mosaic loss of chromosome Y with lung cancer risk and prognosis in a Chinese population. J Thorac Oncol. 2019;14:37-44.
85. García-González P, de Rojas I, Moreno-Grau S, et al. Mendelian randomisation confirms the role of Y-chromosome loss in Alzheimer's disease Aetiopathogenesis in men. Int J Mol Sci. 2023;24:898.
86. Caceres A, Jene A, Esko T, Perez-Jurado LA, Gonzalez JR. Extreme downregulation of chromosome Y and Alzheimer's disease in men. Neurobiol Aging. 2020;90:150.e1-4.
87. Weyrich M, Cremer S, Gerster M, et al. Loss of Y Chromosome and cardiovascular events in chronic kidney disease. Circulation. 2024;150:746-57.
88. Grassmann F, Kiel C, den Hollander AI, et al. Y chromosome mosaicism is associated with age-related macular degeneration. Eur J Hum Genet. 2019;27:36-41.
89. Duan Q, Gao Y, Cao X, et al. Mosaic loss of chromosome Y in peripheral blood cells is associated with age-related macular degeneration in men. Cell Biosci. 2022;12:73.
90. Persani L, Bonomi M, Lleo A, et al. Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis. J Autoimmun. 2012;38:J193-6.
91. Ouseph MM, Hasserjian RP, Dal Cin P, et al. Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells. Haematologica. 2021;106:555-64.
92. Haitjema S, Kofink D, van Setten J, et al. Loss of Y chromosome in blood is associated with major cardiovascular events during follow-up in men after carotid endarterectomy. Circ Cardiovasc Genet. 2017;10:e001544.
93. Dumanski JP, Sundström J, Forsberg LA. Loss of chromosome Y in leukocytes and major cardiovascular events. Circ Cardiovasc Genet. 2017;10:e001820.
94. Dorvall M, Pedersen A, Dumanski JP, et al. Mosaic loss of chromosome Y is associated with functional outcome after ischemic stroke. Stroke. 2023;54:2434-7.
96. Walport LJ, Hopkinson RJ, Vollmar M, et al. Human UTY(KDM6C) is a male-specific Nϵ-methyl lysyl demethylase. J Biol Chem. 2014;289:18302-13.
97. Blair LP, Cao J, Zou MR, Sayegh J, Yan Q. Epigenetic regulation by lysine demethylase 5 (KDM5) enzymes in cancer. Cancers. 2011;3:1383-404.
98. Foresta C, Ferlin A, Moro E. Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum Mol Genet. 2000;9:1161-9.
99. Burgoyne PS, Arnold AP. A primer on the use of mouse models for identifying direct sex chromosome effects that cause sex differences in non-gonadal tissues. Biol Sex Differ. 2016;7:68.
100. Lau YC, Zhang J. Expression analysis of thirty one Y chromosome genes in human prostate cancer. Mol Carcinog. 2000;27:308-21.
101. Wang Y, Sano S. Why Y matters? The implication of loss of Y chromosome in blood and cancer. Cancer Sci. 2024;115:706-14.
102. Mattisson J, Halvardson J, Davies H, et al. Loss of chromosome Y in regulatory T cells. BMC Genomics. 2024;25:243.
103. Putiri EL, Robertson KD. Epigenetic mechanisms and genome stability. Clin Epigenetics. 2011;2:299-314.
104. Suthahar N, Meijers WC, Silljé HHW, de Boer RA. From inflammation to fibrosis-molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities. Curr Heart Fail Rep. 2017;14:235-50.
105. Ljungström V, Mattisson J, Halvardson J, et al. Loss of Y and clonal hematopoiesis in blood-two sides of the same coin? Leukemia. 2022;36:889-91.
106. Baliakas P, Forsberg LA. Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome. Haematologica. 2021;106:329-31.
107. Zhang Q, Zhao L, Yang Y, Li S, Liu Y, Chen C. Mosaic loss of chromosome Y promotes leukemogenesis and clonal hematopoiesis. JCI Insight. 2022;7:153768.
108. Machiela MJ, Zhou W, Karlins E, et al. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nat Commun. 2016;7:11843.
109. Svensson EC, Madar A, Campbell CD, et al. TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial. JAMA Cardiol. 2022;7:521-8.
